Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1985 3
1986 5
1987 10
1988 12
1989 14
1990 21
1991 13
1992 18
1993 16
1994 19
1995 13
1996 9
1997 7
1998 8
1999 8
2000 5
2001 2
2002 8
2003 1
2004 6
2005 2
2006 2
2008 2
2009 5
2010 2
2011 2
2012 2
2013 3
2014 3
2015 4
2016 3
2017 4
2018 2
2019 3
2020 4
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for f moab
Search for F Mojab instead (2 results)
Indolent Lymphomas.
Morschhauser F, Zinzani PL. Morschhauser F, et al. 2022 Feb 7. In: Kröger N, Gribben J, Chabannon C, Yakoub-Agha I, Einsele H, editors. The EBMT/EHA CAR-T Cell Handbook [Internet]. Cham (CH): Springer; 2022. Chapter 15. 2022 Feb 7. In: Kröger N, Gribben J, Chabannon C, Yakoub-Agha I, Einsele H, editors. The EBMT/EHA CAR-T Cell Handbook [Internet]. Cham (CH): Springer; 2022. Chapter 15. PMID: 36122062 Free Books & Documents. Review.
Although promising results were obtained with an immunomodulatory regimen combining anti-C20 Moab and lenalidomide (Leonard et al. 2019; Morschhauser et al. 2019), most current approved therapies do not overcome incremental disease resistance, resulting in multiple lines o …
Although promising results were obtained with an immunomodulatory regimen combining anti-C20 Moab and lenalidomide (Leonard et al. 20 …
Astronaut ophthalmic syndrome.
Zwart SR, Gibson CR, Gregory JF, Mader TH, Stover PJ, Zeisel SH, Smith SM. Zwart SR, et al. FASEB J. 2017 Sep;31(9):3746-3756. doi: 10.1096/fj.201700294. Epub 2017 May 25. FASEB J. 2017. PMID: 28546443
Confirming this hypothesis will help characterize the genetics of 1-carbon pathway metabolism, homocysteine, oxidative stress, endothelial dysfunction, and cardiovascular and potentially other diseases.-Zwart, S. R., Gibson, C. R., Gregory, J. F., Mader, T. H., Stover, P. …
Confirming this hypothesis will help characterize the genetics of 1-carbon pathway metabolism, homocysteine, oxidative stress, endothelial d …
Comparative study of intact A7 MoAb and F(ab')2 fragments for radioimmunoimaging of human colon cancer in nude mice.
Kojima S, Suzuki N, Shimura N, Kubodera A, Kubota K, Yamaguchi T, Takahashi T, Oyamada H. Kojima S, et al. Nucl Med Biol. 1993 Apr;20(3):243-8. doi: 10.1016/0969-8051(93)90044-u. Nucl Med Biol. 1993. PMID: 8485482
The yield of F(ab')2 fragments reached about 50% after ficin treatment for 8 h, and the F(ab')2 retained about 80% of the immunoreactivity of the corresponding MoAb. ...In addition, the tumor image obtained at an early time using 131I-F(ab')2 was much …
The yield of F(ab')2 fragments reached about 50% after ficin treatment for 8 h, and the F(ab')2 retained about 80% of the immu …
Preparation, biodistribution, and dosimetry of 188Re-labeled MoAb ior cea1 and its F(ab')2 fragments by avidin-biotin strategy.
Ferro-Flores G, Pimentel-González G, González-Zavala MA, Arteaga de Murphy C, Meléndez-Alafort L, Tendilla JI, Croft BY. Ferro-Flores G, et al. Nucl Med Biol. 1999 Jan;26(1):57-62. doi: 10.1016/s0969-8051(98)00050-x. Nucl Med Biol. 1999. PMID: 10096502
The biotinylated monoclonal antibody (MoAb) ior cea1 and its F(ab')2 fragments were labeled with Re-188 by combination of avidin-biotin strategy. 188Re-MoAb, 188Re-MoAb-biotin, 188Re-F(ab')2, and 188Re-F(ab')2-biotin preparations were pro …
The biotinylated monoclonal antibody (MoAb) ior cea1 and its F(ab')2 fragments were labeled with Re-188 by combination of avid …
CAR T-Cells in Multiple Myeloma Are Ready for Prime Time.
Rodríguez-Otero P, Prósper F, Alfonso A, Paiva B, San Miguel JF. Rodríguez-Otero P, et al. J Clin Med. 2020 Nov 6;9(11):3577. doi: 10.3390/jcm9113577. J Clin Med. 2020. PMID: 33172026 Free PMC article. Review.
The survival of patients with multiple myeloma (MM) has been dramatically improved in the last decade thanks to the incorporation of second-generation proteasome inhibitors (PI), immunomodulatory drugs (IMID), and, more recently, anti-CD38 monoclonal antibodies (MoAb). Nev …
The survival of patients with multiple myeloma (MM) has been dramatically improved in the last decade thanks to the incorporation of second- …
What is a biocrust? A refined, contemporary definition for a broadening research community.
Weber B, Belnap J, Büdel B, Antoninka AJ, Barger NN, Chaudhary VB, Darrouzet-Nardi A, Eldridge DJ, Faist AM, Ferrenberg S, Havrilla CA, Huber-Sannwald E, Malam Issa O, Maestre FT, Reed SC, Rodriguez-Caballero E, Tucker C, Young KE, Zhang Y, Zhao Y, Zhou X, Bowker MA. Weber B, et al. Biol Rev Camb Philos Soc. 2022 Oct;97(5):1768-1785. doi: 10.1111/brv.12862. Epub 2022 May 18. Biol Rev Camb Philos Soc. 2022. PMID: 35584903 Free PMC article. Review.
Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
Bakchoul T, Boylan B, Sachs UJ, Bein G, Ruan C, Santoso S, Newman PJ. Bakchoul T, et al. Transfusion. 2009 Feb;49(2):265-70. doi: 10.1111/j.1537-2995.2008.01972.x. Epub 2008 Nov 4. Transfusion. 2009. PMID: 19000229 Free PMC article.
The purpose of this investigation was to determine whether SZ21 F(ab')(2) fragments might be therapeutically effective in inhibiting or displacing maternal HPA-1a antibodies from the fetal PLT surface and preventing their clearance from circulation. ...CONCLUSION: F …
The purpose of this investigation was to determine whether SZ21 F(ab')(2) fragments might be therapeutically effective in inhibiting …
Grazing and ecosystem service delivery in global drylands.
Maestre FT, Le Bagousse-Pinguet Y, Delgado-Baquerizo M, Eldridge DJ, Saiz H, Berdugo M, Gozalo B, Ochoa V, Guirado E, García-Gómez M, Valencia E, Gaitán JJ, Asensio S, Mendoza BJ, Plaza C, Díaz-Martínez P, Rey A, Hu HW, He JZ, Wang JT, Lehmann A, Rillig MC, Cesarz S, Eisenhauer N, Martínez-Valderrama J, Moreno-Jiménez E, Sala O, Abedi M, Ahmadian N, Alados CL, Aramayo V, Amghar F, Arredondo T, Ahumada RJ, Bahalkeh K, Ben Salem F, Blaum N, Boldgiv B, Bowker MA, Bran D, Bu C, Canessa R, Castillo-Monroy AP, Castro H, Castro I, Castro-Quezada P, Chibani R, Conceição AA, Currier CM, Darrouzet-Nardi A, Deák B, Donoso DA, Dougill AJ, Durán J, Erdenetsetseg B, Espinosa CI, Fajardo A, Farzam M, Ferrante D, Frank ASK, Fraser LH, Gherardi LA, Greenville AC, Guerra CA, Gusmán-Montalvan E, Hernández-Hernández RM, Hölzel N, Huber-Sannwald E, Hughes FM, Jadán-Maza O, Jeltsch F, Jentsch A, Kaseke KF, Köbel M, Koopman JE, Leder CV, Linstädter A, le Roux PC, Li X, Liancourt P, Liu J, Louw MA, Maggs-Kölling G, Makhalanyane TP, Issa OM, Manzaneda AJ, Marais E, Mora JP, Moreno G, Munson SM, Nunes A, Oliva G, Oñatibia GR, Peter G, Pivari MOD, Pueyo Y, Quiroga RE, Rahmanian S, Reed SC, Rey PJ, Richard B… See abstract for full author list ➔ Maestre FT, et al. Science. 2022 Nov 25;378(6622):915-920. doi: 10.1126/science.abq4062. Epub 2022 Nov 24. Science. 2022. PMID: 36423285
Mitogenic activity of anti-CD28 MoAb CLB-CD28/1 on peripheral blood mononuclear cells and its cooperation with other anti-T cells MoAb in the activation of purified T lymphocytes.
De Felice M, Giarrusso PC, Lamberti A, Turco MC, Valerio G, van Lier RA, Yang SY, Ferrone S, Venuta S. De Felice M, et al. Tissue Antigens. 1990 Jul;36(1):12-8. doi: 10.1111/j.1399-0039.1990.tb01792.x. Tissue Antigens. 1990. PMID: 1701062
The mitogenic activity of MoAb CLB-CD28/1 on PBMC does not require MoAb interaction with monocyte Fc receptors, since F(ab')2 fragments from the MoAb are mitogenic to the same extent as whole IgG. Nevertheless, the activity depends on the presence of a …
The mitogenic activity of MoAb CLB-CD28/1 on PBMC does not require MoAb interaction with monocyte Fc receptors, since F …
Sex and Age Differences in Trail Half Marathon Running.
Navalta JW, Montes J, Tanner EA, Bodell NG, Young JC. Navalta JW, et al. Int J Exerc Sci. 2018 May 1;11(6):281-289. eCollection 2018. Int J Exerc Sci. 2018. PMID: 29795742 Free PMC article.
A significant difference for running velocity was present between sexes at each age category (20-29 yr F = 2.90.3, M = 3.40.4 m.sec(-1); 30-39 yr F = 2.80.3, M = 3.30.3; 40-49 yr F = 2.70.3, M = 3.00.5; 50-59 yr F = 2.30.2, M = 2.80.3; 60-69 yr F …
A significant difference for running velocity was present between sexes at each age category (20-29 yr F = 2.90.3, M = 3.40.4 m.sec(- …
242 results